Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Number of holders
-
34
-
Total 13F shares, excl. options
-
17.8M
-
Shares change
-
-9.74M
-
Total reported value, excl. options
-
$3M
-
Value change
-
-$2.74M
-
Number of buys
-
13
-
Number of sells
-
-22
-
Price
-
$0.17
Significant Holders of GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) as of Q3 2024
52 filings reported holding GLYC - GLYCOMIMETICS INC - Common Stock, par value $0.001 per share as of Q3 2024.
GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.8M shares
.
Largest 10 shareholders include BVF INC/IL (9.54M shares), VANGUARD GROUP INC (2.67M shares), Siren, L.L.C. (1.97M shares), RENAISSANCE TECHNOLOGIES LLC (781K shares), BlackRock, Inc. (728K shares), GEODE CAPITAL MANAGEMENT, LLC (521K shares), ACADIAN ASSET MANAGEMENT LLC (357K shares), TWO SIGMA ADVISERS, LP (249K shares), STATE STREET CORP (179K shares), and NORTHERN TRUST CORP (117K shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.